March 2017
Blue Cross and Blue Care Network no longer cover EpiPen® brand drugs, starting March 1
To provide the best value for our members, Blue Cross Blue Shield of Michigan and Blue Care Network commercial plans no longer cover EpiPen® 0.3 mg and EpiPen Jr® 0.15 mg auto-injector drugs, effective March 1, 2017.
EpiPen injectors are used to treat allergic reactions.
Blue Cross and BCN will provide coverage for the authorized generic epinephrine auto-injectors. These generics are considered brand products and are available to the member at the preferred brand copay amount.
Both the epinephrine auto-injectors and the EpiPen products are manufactured by Mylan and have the same drug formulation and device functionality. Prescriptions written for EpiPen and EpiPen Jr are interchangeable with the ephinephrine auto-injector products when filled at the pharmacy.
Note: These changes don’t apply to MESSA groups.
Here’s a look at the alternatives for excluded drugs and the average cost:
Drugs not covered, beginning March 1, 2017 |
Covered alternatives |
Epipen® (epinephrine injection, 0.3 mg)
2-Pak |
$730** |
Epinephrine 0.3 mg auto injector 2-Pak |
$375** |
Epipen Jr® (epinephrine injection, 0.15 mg) 2-Pak |
$730** |
Epinephrine 0.15 mg auto injector 2- Pak |
$375** |
**Approximate cost per package, based on the average wholesale price
If you’ve been prescribing EpiPen or EpiPen Jr, discuss the covered alternatives with your patients.
|